Collection of Peripheral Blood Mononuclear Cells From Healthy Subjects
NCT05560217 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-09-29
Summary
In accordance with the selection criteria, component blood collection will be carried out and peripheral blood mononuclear cells will be isolated, cryopreserved and in vitro culture of peripheral blood mononuclear cells. Cultivating cells under normal culture conditions or potential drug molecule treatment, observing and recording key parameters such as cell viability, proliferation, apoptosis and functional gene expression, will also provide an important reference for the production of CAR-T cell drugs.
Conditions
- Disease of the Blood
Sponsors & Collaborators
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-10
- Primary Completion
- 2025-09-10
- Completion
- 2025-09-10
More Related Trials
-
Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases
NCT02171949 ·Status: UNKNOWN ·Phase: PHASE2
-
The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults
NCT06224296 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
NCT05794425 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer
NCT00955669 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Collection
NCT00316069 ·Status: TERMINATED
-
Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot
NCT05999656 ·Status: UNKNOWN ·Phase: NA
-
Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI)
NCT00377897 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications
NCT02796079 ·Status: UNKNOWN ·Phase: PHASE1
-
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
NCT01267331 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
NCT03321942 ·Status: UNKNOWN ·Phase: NA
-
Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
NCT04421274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
NCT01446055 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease
NCT04551456 ·Status: UNKNOWN ·Phase: PHASE2
-
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
NCT03253705 ·Status: RECRUITING
-
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia
NCT06359912 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium
NCT03724617 ·Status: COMPLETED ·Phase: NA
-
Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration
NCT01209611 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Collection for Adult Volunteers
NCT00033774 ·Status: TERMINATED
-
Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia
NCT04014166 ·Status: COMPLETED ·Phase: NA
-
Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
NCT02721940 ·Status: UNKNOWN ·Phase: NA
-
Autologous BMMNC Combined With HA Therapy for PAOD
NCT03214887 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Treatment of Chronic Critical Limb Ischemia With G-CSF-mobilized Autologous Peripheral Blood Mononuclear Cells
NCT01833585 ·Status: COMPLETED ·Phase: PHASE3
-
Intraosseous Infusion in Hematologic Critical Patients
NCT07239375 ·Status: RECRUITING
-
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
NCT05689008 ·Status: UNKNOWN ·Phase: PHASE3
-
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
NCT06416709 ·Status: RECRUITING ·Phase: PHASE1/PHASE2